Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients

Blood Cells, Molecules, and Diseases

Volumn 33, Issue 3, 2004, Pages 238-247

  Prigozhina, Tatyana B ^a   Elkin, Gregory ^a   Gurevitch, Olga ^a   Morecki, Shoshana ^a   Yakovlev, Elena ^a   Khitrin, Sofia ^a   Slavin, Shimon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

APLD (alloantigen primed lymphocytes depletion); Bone marrow transplantation; Cyclophosphamide; Reduced intensity conditioning; Transplantation tolerance

Indexed keywords

ALLOANTIGEN; CYCLOPHOSPHAMIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; BONE MARROW CELL; BREAST CARCINOMA; CANCER CELL; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IRRADIATION; LEUKEMIA; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RECIPIENT; SKIN GRAFT; STROMA; WEIGHT REDUCTION;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; LYMPHOCYTES; MICE; MICE, INBRED STRAINS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 7444237063     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2004.08.010     Document Type: Conference Paper

References (36)

1. P.L. Weiden, K.M. Sullivan, N. Flournoy, R. Storb, and E.D. Thomas Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation N. Engl. J. Med. 304 1981 1529 1533
2. R. Hirschhorn Treatment of genetic diseases by allotransplantation Birth Defects, Orig. Artic. Ser. 16 1980 429 444
3. P.B. Medawar Two notes on immunological tolerance Transplant. Bull. 4 2 1957 72 74
4. S. Slavin, S. Strober, Z. Fuks, and H.S. Kaplan Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts J. Exp. Med. 146 1977 34 48
5. Y. Sharabi, and D.H. Sachs Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen J. Exp. Med. 169 2 1989 493 502
6. S. Giralt, E. Estey, and M. Albitar Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 89 1997 4531 4536
7. S. Slavin, A. Nagler, and E. Naparstek Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756 763
8. I.F. Khouri, M. Keating, and M. Korbling Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J. Clin. Oncol. 16 1998 2817 2824
9. P. McSweeney, D. Niederwieser, and J. Shizuru Outpatient allografting with minimally myelosuppressive, immunosuppressive conditioning of low-dose TBI and postgrafting cyclosporine (CSP) and mycophenolate mofetil (MMF) Blood 94 10 Pt. 1 1999 347a Abstract 1742
10. A.M. Carella, R. Champlin, S. Slavin, P. McSweeney, and R. Storb Mini-allografts: ongoing trials in humans Bone Marrow Transplant. 25 2000 345 350
11. J.F. Bach The mode of action of immunosuppressive agents Front. Biol. 41 1975 1 374
12. I.Y. Chernyakhovskaya, E.V. Nagurskaya, G.B. Shaposhnikova, T.B. Prigozhina, and L.N. Fontalin Tolerance to allogeneic and to xenogeneic heart grafts provided by thymectomy of adult mice combined with donor cell and cyclophosphamide inoculation Transplantation 29 1980 409 412
13. I.Y. Chernyakhovskaya, T.B. Prigozhina, E.V. Nagurskaya, and L.N. Fontalin Immunological status of mice with long-standing allogeneic or xenogeneic neonatal heart grafts Transplantation 38 3 1984 267 272
14. H. Mayumi, K. Himeno, T. Shin, and K. Nomoto Drug-induced tolerance to allografts in mice: VI. Tolerance induction in H-2-haplotype-identical strain combinations in mice Transplantation 40 1985 188 194
15. H. Mayumi, M. Umesue, and K. Nomoto Cyclophosphamide-induced immunological tolerance: an overview Immunobiology 195 1996 129 139
16. T.B. Prigozhina, O. Gurevitch, J. Zhu, and S. Slavin Permanent and specific transplantation tolerance induced by a non-myeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytes Transplantation 63 1997 1394 1399
17. S. Slavin, and S. Strober Spontaneous murine B-cell leukaemia Nature 272 1978 624 626
18. D.L. Dexter, H.M. Kowalski, B.A. Blazar, Z. Fligiel, R. Vogel, and G.H. Heppner Heterogeneity of tumor cells from a single mouse mammary tumor Cancer Res. 38 1978 3174
19. G. Elkin, T.B. Prigozhina, O. Gurevitch, and S. Slavin Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice Transplant. Proc. 34 4 2002 1303 1306
20. T.B. Prigozhina, O. Gurevitch, and S. Slavin Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice Exp. Hematol. 27 1999 1503 1510
21. O. Gurevitch, T.B. Prigozhina, T. Pugatsch, and S. Slavin Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment Transplantation 68 1999 1362 1368
22. T.B. Prigozhina, O. Gurevitch, S. Morecki, E. Yakovlev, G. Elkin, and S. Slavin Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models Exp. Hematol. 30 1 2002 89 96
23. R. Yasumizu, K. Sugiura, and H. Iwai Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue Proc. Natl. Acad. Sci. U. S. A. 84 18 1987 6555 6557
24. G. Elkin, T.B. Prigozhina, and S. Slavin Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation Exp. Hematol. 32 6 2004 579 584
25. E. Bachar-Lustig, N. Rachamim, H.W. Li, F. Lan, and Y. Reisner Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat. Med. 1 12 1995 1268 1273
26. P. Reddy, and J.L. Ferrara Immunobiology of acute graft-versus-host disease Blood 17 4 2003 187 194
27. C.Q. Xun, J.S. Thompson, C.D. Jennings, S.A. Brown, and M.B. Widmer Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 83 8 1994 2360 2367
28. B.R. Blazar, C.J. Lees, and P.J. Martin Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions J. Immunol. 165 2000 4901 4909
29. S.A. Quezada, B. Fuller, L.Z. Jarvinen, M. Gonzalez, B.R. Blazar, A.Y. Rudensky, T.B. Strom, and R.J. Noelle Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation Blood 102 5 2003 1920 1926
30. N.J. Monk, R.E. Hargreaves, and J.E. Marsh Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade Nat. Med. 9 2003 1275 1280
31. E. Seung, J.P. Mordes, A.A. Rossini, and D.L. Greiner Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning J. Clin. Invest. 112 5 2003 795 808
32. Y. Takeuchi, H. Ito, J. Kurtz, T. Wekerle, L. Ho, and M. Sykes Earlier low-dose TBI or DST overcomes CD8+T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L Am. J. Transplant. 4 1 2004 31 40
33. J. Kurtz, J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes Mechanisms of early peripheral CD4 T cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion, but not regulatory cells Blood 103 11 2004 4336 4343
34. T.B. Prigozhina, O. Gurevitch, G. Elkin, S. Morecki, E. Yakovlev, and S. Slavin CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells Exp. Hematol 31 1 2003 81 88
35. M. Abedi, D. Greer, J.F. Lambert, G.A. Colvin, M.S. Dooner, C.I. McAuliffe, D. Demers, B.E. Moore, and P.J. Quesenberry Tolerance induction by costimulator blockade in 100 cGy treated hosts with varying degrees of genetic disparity Leukemia 17 9 2003 1871 1879
36. T. Kawai, D. Andrews, R.B. Colvin, D.H. Sachs, and A.B. Cosimi Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand Nat. Med. 6 2 2000 114